Solventum Corp reported $2.94B in Current Liabilities for its fiscal quarter ending in September of 2025.





Current Liabilities Change Date
Abbott USD 14.58B 1.14B Sep/2025
Align Technology USD 1.97B 29.02M Sep/2025
Baxter International USD 3.78B 836M Sep/2025
Becton, Dickinson and Co. USD 8.31B 153M Sep/2025
Cencora USD 57.82B 3.86B Sep/2025
Dexcom USD 3.34B 27.3M Sep/2025
Insulet USD 647.7M 362.4M Sep/2025
Solventum Corp USD 2.94B 318M Sep/2025
West Pharmaceutical Services USD 635.4M 30.8M Sep/2025
Zimmer Biomet Holdings USD 2.4B 296.6M Sep/2025